Compare, Analyse Abbott India with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs MYLAN (US) - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ABBOTT INDIA   MYLAN
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
MYLAN
Dec-18
ABBOTT INDIA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs8,8343,498-   
Low Rs5,4581,925-   
Sales per share (Unadj.) Rs1,731.11,609.6-  
Earnings per share (Unadj.) Rs211.943.7-  
Cash flow per share (Unadj.) Rs219.9345.1-  
Dividends per share (Unadj.) Rs65.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs945.21,741.3-  
Shares outstanding (eoy) m21.25514.50-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.11.7 245.0%   
Avg P/E ratio x33.762.0 54.3%  
P/CF ratio (eoy) x32.57.9 413.6%  
Price / Book Value ratio x7.61.6 485.5%  
Dividend payout %30.70-   
Avg Mkt Cap Rs m151,8481,395,211 10.9%   
No. of employees `0003.535.0 10.0%   
Total wages/salary Rs m4,3560-   
Avg. sales/employee Rs Th10,555.523,661.7 44.6%   
Avg. wages/employee Rs Th1,249.90-   
Avg. net profit/employee Rs Th1,292.2642.5 201.1%   
INCOME DATA
Net Sales Rs m36,786828,159 4.4%  
Other income Rs m1,1330-   
Total revenues Rs m37,919828,159 4.6%   
Gross profit Rs m6,047214,297 2.8%  
Depreciation Rs m169155,064 0.1%   
Interest Rs m2339,832 0.1%   
Profit before tax Rs m6,98919,401 36.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,485-3,087 -80.5%   
Profit after tax Rs m4,50322,488 20.0%  
Gross profit margin %16.425.9 63.5%  
Effective tax rate %35.6-15.9 -223.5%   
Net profit margin %12.22.7 450.8%  
BALANCE SHEET DATA
Current assets Rs m27,610462,443 6.0%   
Current liabilities Rs m8,569337,172 2.5%   
Net working cap to sales %51.815.1 342.2%  
Current ratio x3.21.4 234.9%  
Inventory Days Days6084 72.0%  
Debtors Days Days2793 29.4%  
Net fixed assets Rs m1,057160,649 0.7%   
Share capital Rs m213441 48.2%   
"Free" reserves Rs m19,8730-   
Net worth Rs m20,086895,917 2.2%   
Long term debt Rs m0966,981 0.0%   
Total assets Rs m29,4092,403,196 1.2%  
Interest coverage x311.61.5 20,953.7%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x1.30.3 363.0%   
Return on assets %15.42.6 593.4%  
Return on equity %22.42.5 893.2%  
Return on capital %34.93.2 1,097.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-4,5490-   
CASH FLOW
From Operations Rs m4,991172,092 2.9%  
From Investments Rs m-2,570-88,952 2.9%  
From Financial Activity Rs m-1,428-80,170 1.8%  
Net Cashflow Rs m9931,426 69.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.49 Rs / USD

Compare ABBOTT INDIA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ABBOTT INDIA With: BIOCON   WOCKHARDT  SHASUN PHARMA  ALKEM LABORATORIES  DIVIS LABORATORIES  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

New Research: Our #1 Stock Pick Right Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ABBOTT INDIA SHARE PRICE


May 14, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ABBOTT INDIA

ABBOTT INDIA - AJANTA PHARMA COMPARISON

COMPARE ABBOTT INDIA WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS